News | Common ‘Forever Chemical’ PFOA Disrupts Hormone Signaling and Impairs Embryo Implantation in Mice



News | Study finds: Common "forever chemical" PFOA disrupts hormone signaling and significantly impairs embryo implantation ability in mice


A new animal study suggests that perfluorooctanoic acid (PFOA), widely present in the everyday environment, may significantly weaken the key biological basis for successful embryo implantation by interfering with hormone regulation and endometrial function, thereby posing a potential threat to female fertility.


Petals material_Medical or scientific researcher or male doctor observing test tubes with transparent solution in laboratory_184612631.jpg


The study was completed by a research team from Iran University of Medical Sciences, and the findings were published in Reproductive and Developmental Medicine. Using mice as a model, the researchers systematically evaluated the effects of oral exposure to different doses of PFOA during the critical implantation window in early pregnancy on ovarian hormone secretion, endometrial morphology, and molecular signaling pathways.


PFOA belongs to the per- and polyfluoroalkyl substances (PFAS) family, and is called a "forever chemical" because it is extremely difficult to degrade in the environment and can accumulate in the human body over the long term. These substances are widely present in non-stick pan coatings, food packaging materials, contaminated drinking water, and many consumer products. Previous studies have linked PFAS exposure to menstrual disorders, diminished ovarian reserve, and earlier menopause, but direct evidence of its impact on embryo implantation, a critical reproductive step, has been lacking.


In this study, the researchers administered different doses of PFOA orally to mice during the critical pregnancy period around embryo implantation, and then measured serum hormone levels, ultrastructural changes in the endometrium, and the expression of genes related to endometrial receptivity.


The results showed that PFOA exposure significantly reduced serum progesterone levels in mice. Progesterone is a core hormone for maintaining early pregnancy and promoting the transformation of the endometrium into a "receptive state," and its decline means the uterine environment can hardly provide the necessary support for the embryo.


At the histological level, the study also observed that PFOA caused a dose-dependent reduction in the number of pinopodes on the endometrial surface. Pinopodes are considered important structures for the initial contact and adhesion between the embryo and the endometrium, and their loss directly weakens the embryo's ability to attach.


At the molecular level, PFOA significantly inhibited the expression of interleukin-1β (IL-1β) and interleukin-6 (IL-6). These two cytokines play a central role in the communication between the embryo and the endometrium, participating in the regulation of immune tolerance, cell adhesion, and tissue remodeling. Their downregulation suggests that PFOA may disrupt the "molecular dialogue" between the embryo and the maternal uterus, thereby increasing the risk of implantation failure.


The study authors concluded that PFOA acts through multiple pathways to systematically weaken endometrial receptivity. "By reducing progesterone production, decreasing pinopode formation, and inhibiting IL-1β and IL-6 expression, PFOA creates a uterine environment unfavorable for embryo implantation."


The researchers also emphasized that the study is based on an animal model, and the results still need to be further validated in humans. However, against the backdrop of widespread PFAS exposure in the modern living environment, this finding once again highlights the importance of environmental endocrine disruptors in reproductive medicine. "Given the ubiquitous exposure to these chemicals in daily life, a deeper understanding of their relationship with infertility is of practical and urgent significance for protecting reproductive health."


Story source:

Collected from the internet

Author LinkedIVF TeamPublished 2026-01-28
This article used AI assistance; LinkedIVF has not recorded an editorial review for this item. It is not medical advice.
This content is for informational purposes only and does not constitute medical advice. Please consult a licensed physician. Content guidelines & editorial policy

We Will Contact You Soon

Enter your details and we will contact you as soon as possible.
  • Preimplantation Genetic Testing and IVF
    Donor Egg or Sperm IVF
    Third-Party Reproduction Information (Subject to Local Law)
    Other